Nicholas Galakatos, Director, 10% Owner at Entasis Therapeutics Holdings Inc. (ETTX), bought 865,978 shares at $15.00 ($6.8M) on 2018-09-28, disclosed to the SEC on 2018-10-02.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 412,583 | $0 | 0.0% |
| 2 | $15.00 | 453,395 | $6.8M | 100.0% |
| Total | $7.85 avg | 865,978 | $6.8M | 100% |
| Filing → |
| OPHT | SELL | 2016-01-13 | $197K | — | Filing → |
| OPHT | SELL | 2015-12-14 | $193K | — | Filing → |
| OPHT | SELL | 2015-11-19 | $90K | — | Filing → |